QualityStocksNewsBreaks Archives - Page 414 of 1387

TuesdayApr 12, 2022 12:26 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Participate in Upcoming Virtual Investor Event

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be part of a moderated fireside chat during the Virtual Investor Glioblastoma Multiforme (“GBM”) Spotlight event on April 14, 2022. The chat is scheduled for 11:30 a.m. ET and will include CNS Pharmaceuticals management team members, including CEO John Climaco, along with opinion leader Samuel A. Goldlust, MD. The focus of the chat will be GBM and the work that CNS Pharmaceuticals is doing to advance Berubicin, its novel anthracycline and the first anthracycline to…

MondayApr 11, 2022 3:09 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Taking Diverse Product Portfolio to New Markets

Flora Growth Corp. (NASDAQ: FLGC) recently announced the successful import of Mambe CBD-containing food and beverage products into the United States from Colombia. The move capitalized on a new law signed by Colombian President Ivan Duque, which provides the necessary regulatory framework for cannabis product use and export. “Our team anticipated this regulatory update and has been laying the necessary foundation to expand this new supply chain pathway allowing Flora to quickly bring our diverse product portfolio and low-cost cannabis inputs to new high-growth international markets,” a recent article quotes Flora Growth CEO Luis Merchan as saying. Flora Growth also…

MondayApr 11, 2022 1:52 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Better Equips Itself for Long-Term Growth Plans

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, has promoted four employees to executive positions. Doris Lam has been named vice president of finance, Jason M Gonzalez has been named senior vice president of client development, Ronald J Gallegos has been named vice president of client experience and Ryan J Fanciullo has been named vice president of operations. According to the announcement, these employees have demonstrated exceptional leadership abilities and have been promoted to capitalize on Knightscope’s current momentum as the company continues focusing on product innovation and sales growth. The new…

MondayApr 11, 2022 1:34 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Completes Name and Ticker Symbol Change

Correlate Infrastructure Partners (OTCQB: CIPI) today announced completion of the company’s corporate name change from Triccar Inc. to Correlate Infrastructure Partners Inc. In conjunction with the name change, the company’s ticker symbol changed to CIPI, effective at the open of market trading on April 11, 2022. “This name change accurately reflects Correlate's Net Zero solution scope for property owners while making it clear we are an open ecosystem supporting industry partners across North America,” said Correlate Infrastructure Partners CEO Todd Michaels. “Since the merger of two operating companies, Correlate Inc. and Loyal Enterprises LLC (dba Solar Site Design) in December…

MondayApr 11, 2022 1:22 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Beginning of New Nicotine Formulation Creation, Evaluation Program

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has entered agreements with Altria Client Services LLC. According to the announcement, the agreements call for Lexaria to provide specific DehydraTECH(TM) powder-based nicotine formulations for a fee; Altria in turn will evaluate the formulations. The new agreements will continue through March 31, 2023. Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. In addition, the technology has shown the ability to increase bioabsorption with cannabinoids and nicotine by up to 10 times as well as decrease time…

MondayApr 11, 2022 12:35 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Releases New Corporate Presentation, Announces Steady Growth in Key Categories

Friendable (OTC: FDBL) today released a new corporate presentation and 2022 strategy and announced additional increases in certain key metrics driving the company’s growth, as its 360 offering sees increased traction, revenue and user retention. As the Fan Pass Live platform has expanded, the company’s other brands associated with its 360 offering have exceeded expectations, with the Artist Republik and FeaturedX products and services continuing to produce positive results. “Hearing from our artists, their experiences, as well as simply listening to how our offering can better support their journey to success has been one of the most rewarding parts of…

MondayApr 11, 2022 11:40 am

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) Names Seasoned Transactional Attorney to Board of Directors

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has named a new member of its board of directors. The company has appointed transactional lawyer Adele Hogan to the board; Hogan will replace Carl Williams. With more than three decades of experience, Hogan has been involved in an estimated $200 billion of securities, mergers, contracts and closed deals. She is currently a partner at Lucosky Brookman, where she also serves as the cochair of the Corporate, Mergers & Securities Practice Group overseeing mergers and capital markets transactions including IPOs, SPACs, de-SPACs, corporate side of bankruptcies, securities and derivatives. Previously…

FridayApr 08, 2022 3:37 pm

QualityStocksNewsBreaks – Hero Technologies Inc. (HENC) Focusing on Expansion of Current Operations, Future Industry Growth

Hero Technologies (OTC: HENC) has made key acquisitions and investments that have played an essential role in its strategic business plan and operations. During a recent episode of the Bell2Bell Podcast hosted by Stuart Smith, company CEO Gina Serkasevich discussed HENC’s careful expansion moves. “In 2020, ‘both Highly Relaxing and the assets of V Brokers, under Veteran Hemp Co., were acquired,’ said Serkasevich. ‘Both of these entities gave Hero a foot in the door to establish itself as a cannabis player. Since then, our biggest advancement was becoming a majority stakeholder in BlackBox Systems and Technologies,’” a recent article reads.…

FridayApr 08, 2022 2:56 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Eyeing Additional Investments to Expand Portfolio Companies’ Reach

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF), a growing company strengthening its end-to-end supply chain production of nutritious foods through strategic acquisitions, is working to overcome global forces such as the war in Ukraine in its efforts to transform entire industries such as meat and dairy with nutrition-focused operations. “The world is witnessing one of the worst global supply chains in history. Getting products in containers on planes, trains and ships to meet the demand remains a formidable task; however, I have the utmost confidence in our teams and partners…. We continue to deploy the utmost of business pragmatism…

FridayApr 08, 2022 2:29 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Hopes to Demonstrate DehydraTECH’s Superior Performance in Ongoing Epilepsy Research Program

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced the beginning of the first phase of its epilepsy research program, EPIL-A21-1. “The research program will assess the seizure-inhibiting activity of cannabidiol (‘CBD’) administered via the company’s proprietary DehydraTECH(TM) technology, compared to the only FDA-approved CBD-based seizure medication…. The EPIL-A21-1 research program contains two main studies to be performed in rodents following the first phase – a pilot animal model that has already begun. The main studies are slated to commence in May/June and involve an acute seizure model induced by electrical stimulation and chemically induced seizure models,” a recent article reads. “Using…

Site Search

Company Search

Category: QualityStocksNewsBreaks